| J3262 | Injection, tocilizumab, 1 mg | 136,570 | $10 | $682.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14,530 | $30 | $493.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 33,230 | $10 | $332.3K |
| J0897 | Injection, denosumab, 1 mg | 16,080 | $20 | $289.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 24,990 | $10 | $199.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,430 | $30 | $115.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,250 | $90 | $109.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 370 | $100 | $35.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 170 | $120 | $21.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 410 | $50 | $20.2K |